Unlike FDA-approved medicines, compounded GLP-1 drugs and products promoted as alternatives to the FDA-approved versions such as oral supplements and patches do not go through the FDAs rigorous review process to ensure safety, effectiveness, and quality
Supported by our expert clinician care team
Rapid weight loss without adequate fat intake concentrates bile and increases gallstone risk
Recalls & Warnings August 18, 2017 FDA Warns Consumers Not to Use Certain Liquid Multis, Vitamin D, and Other Supplements Due to Potential Bacterial Contamination On August 11, 2017, the FDA advised the public not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals, and Leader Brands, because they have the potential to be contaminated with
GHK-Cu 50 Pen Unavailable Fast, secure cold-chain delivery
Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi